Large number of individuals, such as recovery and rescue workers, nearby residents and office workers, who experienced intense or prolonged exposure to the World Trade Center attack have reported new diagnoses of asthma or posttraumatic stress 5-6 years after the attack, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.

"The September 11, 2001, terrorist attack on the World Trade Center (WTC) killed thousands and exposed hundreds of thousands to horrific events and potentially harmful environmental conditions resulting from the collapsing towers and fires," according to background information in the article. Studies have documented adverse respiratory and mental health conditions associated with direct exposure within 1 to 3 years following the event, however, the longer-term impact on health has been unclear.

Robert M. Brackbill, Ph.D., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues of the New York City Department of Health and Mental Hygiene, and Columbia University, New York, examined the incidence of two of the most commonly reported health outcomes: asthma and posttraumatic stress (PTS) symptoms indicative of probable posttraumatic stress disorder (PTSD) among adults 5 to 6 years after the attack. The researchers used data from the World Trade Center Health Registry, the largest postdisaster exposure registry in U.S. history, which prospectively follows a group that reported a range of WTC disaster - associated exposures on September 11 and during its immediate aftermath. Wave 1 of the study, conducted in 2003-2004, included enrollment of 71,437 adults in four groups: rescue/recovery workers, lower Manhattan residents, lower Manhattan office workers, and passersby; 46,322 adults (68 percent) completed a follow-up wave 2 survey in 2006-2007. The surveys included questions regarding symptoms of asthma following September 11 and event-related PTS symptoms indicative of probable PTSD, assessed using the PTSD Checklist (a self-report symptoms rating scale).

The researchers found that overall postevent incidence among those without a prior history of asthma was 10.2 percent, with rescue/recovery workers having higher postevent asthma diagnosis rates than the next highest group, passersby on September 11 (12.2 percent vs. 8.6 percent). For all eligibility groups combined, intense dust cloud exposure was associated with postevent diagnoses of asthma (13.5 percent vs. 8.4 percent for no dust cloud exposure). Thirty-nine percent of all respondents reporting postevent diagnoses of asthma also reported intense dust cloud exposure.

"These analyses confirm that intense dust cloud exposure was associated with new asthma diagnoses for each eligibility group, including the 1,913 passersby who only had exposure to the area air and dust on September 11," the authors write.

Among rescue/recovery workers, risk for asthma was highest among those who worked on the pile on September 11, with risk diminishing with later start dates. Asthma risk also was independently associated with some damage to home or office, and risk was highest if there was a heavy coating of dust at home or at the office. Among residents, those who did not evacuate reported higher rates of asthma than those who did.

Of the adults without a diagnosis of PTSD before September 11, 23.8 percent screened positive for PTS symptoms indicative of probable PTSD at either wave 1 (14.3 percent) or wave 2 (19.1 percent). At follow-up, the prevalence of PTS symptoms increased in every eligibility group, with the greatest increase occurring among rescue/recovery workers. At the wave 2 follow-up survey, passersby had the highest levels of symptoms (23.2 percent), while residents had the lowest (16.3 percent).

Across eligibility groups, passersby had the highest prevalence of chronic PTS symptoms and office workers had the highest prevalence of resolved symptoms while rescue/recovery workers had the highest prevalence of late-onset symptoms. With regard to mental health diagnoses, 13.6 percent of all participants previously free of PTSD reported receiving a PTSD diagnosis from a mental health professional since September 11; 14.0 percent reported receiving a depression diagnosis; and 7.4 percent reported receiving both. Event-related loss of spouse or job was associated with PTS symptoms.

Co-occurrence of postevent asthma and PTS symptoms was common in the follow-up survey. Among enrollees with postevent asthma, 36 percent had PTS symptoms; among enrollees with these symptoms at follow-up, 19 percent reported a new diagnosis of asthma after September 11.

The researchers add that applying reported outcome rates from the follow-up survey results to the approximately 409,000 potentially exposed persons, roughly 25,500 adults are estimated to have experienced postevent asthma and 61,000 are estimated to have experienced symptoms indicative of probable PTSD.

"Our findings confirm that, after a terrorist attack, mental health conditions can persist if not identified and adequately treated and that a substantial number of exposed persons may develop late-onset symptoms. Our study highlights the need for surveillance, outreach, treatment, and evaluation of efforts for many years following a disaster to prevent and mitigate health consequences," the authors conclude.

JAMA. 2009;302[5]:502-516.

Source
Journal of the American Medical Association

Tag Cloud

Buy Actonel Without Prescription
Buy Adefovir Without Prescription
Buy Allopurinol Without Prescription
Buy Antabuse Without Prescription
Buy Arava Without Prescription
Buy Armour Without Prescription
Buy Atarax Without Prescription
Buy Azathioprine Without Prescription
Buy Bayer ASA Aspirin Without Prescription
Buy CellCept Without Prescription
Buy Colchicine Without Prescription
Buy Cyklokapron Without Prescription
Buy Cystone Without Prescription
Buy Detrol Without Prescription
Buy Dexamethasone Without Prescription
Buy Diamox Without Prescription
Buy Diltiazem Cream Without Prescription
Buy Ditropan Without Prescription
Buy Epogen Without Prescription
Buy Fosamax Without Prescription
Buy HIV Test Without Prescription
Buy Human Growth Hormone Without Prescription
Buy Kenalog Without Prescription
Buy Meclizine Without Prescription
Buy Mestinon Without Prescription
Buy Motilium Without Prescription
Buy Naltrexone Without Prescription
Buy Nimotop Without Prescription
Buy Persantine Without Prescription
Buy Potassium Citrate Without Prescription
Buy Prednisolone Without Prescription
Buy Probenecid Without Prescription
Buy Prograf Without Prescription
Buy Pyridium Without Prescription
Buy Reglan Without Prescription
Buy Rocaltrol Without Prescription
Buy Rogaine Without Prescription
Buy Synthroid Without Prescription
Buy Triamcinolone Without Prescription
Buy Urispas Without Prescription
Buy Urivoid Without Prescription
Buy Ursodiol Without Prescription
Buy Vasodilan Without Prescription
Buy Vesicare Without Prescription
Buy Zofran Without Prescription
Buy Anti Flu Face Mask Without Prescription
Buy Anti-Bacterial Face Mask Without Prescription
Buy Atripla Without Prescription
Buy Combivir Without Prescription
Buy Didanosine Without Prescription
Buy Epivir Without Prescription
Buy Famvir Without Prescription
Buy Nevirapine Without Prescription
Buy Retrovir Without Prescription
Buy Ribavirin Without Prescription
Buy Stavudine Without Prescription
Buy Sustiva Without Prescription
Buy Truvada Without Prescription
Buy Valtrex Without Prescription
Buy Zovirax Without Prescription